Back to search

Article

A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapy

2020-08-22

Abstract excerpt

<title>Abstract</title> <p><bold>Background:</bold> In this study we aimed to identify a prognostic signature in <italic>BRCA1/2</italic> mutations to predict disease progression and the efficiency of chemotherapy ovarian cancer (OV), the second most common cause of death from gynecologic cancer in women worldwide. <bold>Methods: </bold>Univariate Cox proportional-hazards and multivariate Cox regression analyses...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5cff1eb0-fa3f-5af4-999f-00dfdd6c93a1
DOI
10.21203/rs.3.rs-28390/v2
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
A novel signature of two long non-coding RNAs in BRCA mutant ovarian cancer to predict prognosis and efficiency of chemotherapyDOI 10.21203/rs.3.rs-28390/v2
Select a neighboring publication to make it the new centre.